Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization

Cell Cycle

Volumn 13, Issue 1, 2014, Pages 115-125

  Polonio Vallon, Tilman ^a   Kirkpatrick, Joanna ^b   Krijgsveld, Jeroen ^b   Hofmann, Thomas G ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Apoptosis; Chemotherapeutic drug; HIPK2; P53; Src

Indexed keywords

DASATINIB; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PROTEIN P53; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

APOPTOSIS; CHEMOTHERAPEUTIC DRUG; HIPK2; P53; SRC;

APOPTOSIS; CARRIER PROTEINS; DNA DAMAGE; HCT116 CELLS; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE; SRC-FAMILY KINASES; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 84892619755     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26857     Document Type: Article

References (36)

1. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004; 23:7906-9; PMID:15489908; http://dx.doi.org/10. 1038/sj.onc.1208160 (Pubitemid 39468849)
2. Tice DA, Biscardi JS, Nickles AL, Parsons SJ. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A 1999; 96: 1415-20; PMID:9990038; http://dx.doi.org/10.1073/pnas. 96.4.1415 (Pubitemid 29098465)
3. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004; 6:209-14; PMID:15380511; http://dx.doi.org/10.1016/j.ccr.2004. 09.001 (Pubitemid 39222033)
4. Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, Xiong Y, Tseng LM, Li SH, Ding Z, et al. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med 2011; 17: 461-9; PMID:21399647; http://dx.doi.org/10.1038/nm.2309
5. Zhang S, Yu D. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharmacol Sci 2012; 33: 122-8; PMID:22153719; http://dx.doi.org/10.1016/j.tips.2011.11.002
6. Kmiecik TE, Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 1987; 49: 65-73; PMID:3103925; http://dx.doi.org/10.1016/ 0092-8674(87)90756-2
7. Kmiecik TE, Johnson PJ, Shalloway D. Regulation by the autophosphorylation site in overexpressed pp60csrc. Mol Cell Biol 1988; 8: 4541-6; PMID:2460746
8. Hofmann TG, Glas C, Bitomsky N. HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis. Bioessays 2013; 35: 55-64; PMID:23169233; http://dx.doi.org/10.1002/bies.201200060
9. Calzado MA, de la Vega L, Möller A, Bowtell DD, Schmitz ML. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol 2009; 11:85-91; PMID:19043406; http://dx.doi.org/10. 1038/ncb1816
10. Hikasa H, Ezan J, Itoh K, Li X, Klymkowsky MW, Sokol SY. Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification. Dev Cell 2010; 19: 521-32; PMID:20951344; http://dx.doi.org/10.1016/j.devcel.2010. 09.005
11. Bitomsky N, Hofmann TG. Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling -roles of p53, p73 and HIPK2. FEBS J 2009; 276: 6074-83; PMID:19788416; http://dx.doi.org/10.1111/j.1742-4658.2009.07331.x
12. Dauth I, Krüger J, Hofmann TG. Homeodomaininteracting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 2007; 67: 2274-9; PMID:17332358; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2884 (Pubitemid 46424247)
13. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008; 10: 812-24; PMID:18536714; http://dx.doi.org/10.1038/ncb1743 (Pubitemid 351927710)
14. Choi DW, Seo YM, Kim EA, Sung KS, Ahn JW, Park SJ, Lee SR, Choi CY. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 2008; 283: 4682-9; PMID:18093972; http://dx.doi.org/10.1074/jbc.M708873200
15. Bitomsky N, Conrad E, Moritz C, Polonio-Vallon T, Sombroek D, Schultheiss K, Glas C, Greiner V, Herbel C, Mantovani F, et al. Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death. Proc Natl Acad Sci U S A 2013; In press; PMID:24145406; http://dx.doi.org/10.1073/ pnas.1310001110
16. Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Dröge W, Will H, Schmitz ML. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4: 1-10; PMID:11740489; http://dx.doi.org/10.1038/ncb715 (Pubitemid 34071974)
17. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, et al. Homeodomaininteracting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11-9; PMID:11780126; http://dx.doi.org/10.1038/ncb714
18. Möller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Dröge W, Will H, Schmitz ML. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 2003; 63: 4310-4; PMID:12907596 (Pubitemid 36950995)
19. Krieghoff-Henning E, Hofmann TG. Role of nuclear bodies in apoptosis signalling. Biochim Biophys Acta 2008; 1783: 2185-94; PMID:18680765; http://dx.doi.org/10.1016/j.bbamcr.2008.07.002
20. Bernardi R, Papa A, Pandolfi PP. Regulation of apoptosis by PML and the PML-NBs. Oncogene 2008; 27: 6299-312; PMID:18931695; http://dx.doi.org/10.1038/ onc.2008.305
21. Crone J, Glas C, Schultheiss K, Moehlenbrink J, Krieghoff-Henning E, Hofmann TG. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis. Cancer Res 2011; 71: 2350-9; PMID:21248071; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-3486
22. Siepi F, Gatti V, Camerini S, Crescenzi M, Soddu S. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation. Biochim Biophys Acta 2013; 1833:1443-53; PMID:23485397; http://dx.doi.org/10.1016/j.bbamcr.2013.02.018
23. Saul VV, de la Vega L, Milanovic M, Krüger M, Braun T, Fritz-Wolf K, Becker K, Schmitz ML. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 2013; 5: 27-38; PMID:23000554; http://dx.doi.org/10.1093/jmcb/mjs053
24. Yun S, Möller A, Chae SK, Hong WP, Bae YJ, Bowtell DD, Ryu SH, Suh PG. Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase Cepsilon. J Biol Chem 2008; 283: 1034-42; PMID:17998205; http://dx.doi.org/10.1074/jbc.M705874200
25. Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003; 115:177-86; PMID:14567915; http://dx.doi.org/10.1016/S0092-8674(03)00802-X (Pubitemid 37329581)
26. Mao JH, Wu D, Kim IJ, Kang HC, Wei G, Climent J, Kumar A, Pelorosso FG, DelRosario R, Huang EJ, et al. Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma. Oncogene 2012; 31: 1176-80; PMID:21785465; http://dx.doi.org/10.1038/onc.2011.306
27. Lavra L, Rinaldo C, Ulivieri A, Luciani E, Fidanza P, Giacomelli L, Bellotti C, Ricci A, Trovato M, Soddu S, et al. The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas. PLoS One 2011; 6:e20665; PMID:21698151; http://dx.doi.org/ 10.1371/journal.pone.0020665
28. Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J, Mao JH, Appella E, Balmain A, Huang EJ. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci U S A 2007; 104: 13040-5; PMID:17666529; http://dx.doi.org/10.1073/pnas.0703213104 (Pubitemid 351737589)
29. Lochhead PA, Sibbet G, Morrice N, Cleghon V. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 2005; 121: 925-36; PMID:15960979; http://dx.doi.org/10.1016/j.cell. 2005.03.034 (Pubitemid 40806423)
30. Wee HJ, Voon DC, Bae SC, Ito Y. PEBP2-beta/CBFbeta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood 2008; 112: 3777-87; PMID:18695000; http://dx.doi.org/10.1182/blood-2008- 01-134122
31. Muschik D, Braspenning-Wesch I, Stockfleth E, Rösl F, Hofmann TG, Nindl I. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One 2011; 6:e27655; PMID:22110707; http://dx.doi.org/10.1371/ journal.pone.0027655
32. Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, Aikawa Y, Kimura A, Kitabayashi I. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1-and p53-mediated transcription. Oncogene 2007; 26: 7231-9; PMID:17533375; http://dx.doi.org/10.1038/sj.onc.1210523 (Pubitemid 350085316)
33. Cursi S, Rufini A, Stagni V, Condò I, Matafora V, Bachi A, Bonifazi AP, Coppola L, Superti-Furga G, Testi R, et al. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J 2006; 25: 1895-905; PMID:16619028; http://dx.doi.org/10.1038/sj.emboj. 7601085
34. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128: 281-94; PMID:17254967; http://dx.doi.org/10.1016/j.cell. 2006.11.049 (Pubitemid 46123510)
35. Krieghoff-Henning E, Hofmann TG. HIPK2 and cancer cell resistance to therapy. Future Oncol 2008; 4: 751-4; PMID:19086839; http://dx.doi.org/10.2217/ 14796694.4.6.751
36. Marchini FK, de Godoy LM, Rampazzo RC, Pavoni DP, Probst CM, Gnad F, Mann M, Krieger MA. Profiling the Trypanosoma cruzi phosphoproteome. PLoS One 2011; 6:e25381; PMID:21966514; http://dx.doi.org/10.1371/journal.pone.0025381